EUVIMEDEUVIMED entdecken
Open Access

In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models

Tadashi Ashizawa, Akira Iizuka, Akari Kanematsu, Takayuki Ando, Chie Maeda, Haruo Miyata, Kazue Yamashita, Tomoatsu Ikeya, Yasufumi Kikuchi, Kouji Maruyama, Takeshi Nagashima, Kenichi Urakami und 2 weitere

In Vivo · 2025

DOI: 10.21873/invivo.13805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Tadashi Ashizawa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan. Hauptthemen laut MEDLINE: Disease Models, Animal, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, B7-H1 Antigen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalProgrammed Cell Death 1 ReceptorCD8-Positive T-LymphocytesB7-H1 AntigenImmune Checkpoint InhibitorsLymphocytes, Tumor-InfiltratingAnimalsMiceCell Line, TumorNeoplasmsFemaleHumansImmunotherapy

Stichwörter der Autor:innen

PD-1/PD-L1 inhibitormouse syngeneic tumorssmall chemical compoundtumor mutation burden (TMB)tumor-infiltrating lymphocyte (TIL)

Substanzen

Programmed Cell Death 1 ReceptorB7-H1 AntigenImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Department of Drug and Food Science, Shizuoka Institute of Environment and Hygiene, Shizuoka, Japan.
  • Experimental Animal Facility, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • SRL, Tokyo, Japan.
  • Cancer Diagnostic Research Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan.
  • Office of the President Emeritus, Shizuoka Cancer Center Hospital, Shizuoka, Japan.

Zitieren

APA

Ashizawa, T., Iizuka, A., Kanematsu, A., Ando, T., Maeda, C., Miyata, H., Yamashita, K., Ikeya, T., Kikuchi, Y., Maruyama, K., Nagashima, T., Urakami, K., Yamaguchi, K., & Akiyama, Y. (2025). In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models. In Vivo. https://doi.org/10.21873/invivo.13805

Vancouver

Ashizawa T, Iizuka A, Kanematsu A, Ando T, Maeda C, Miyata H, et al. In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models. In Vivo. 2025. doi:10.21873/invivo.13805

BibTeX
@article{Ashizawa2025,
  author = {Ashizawa, Tadashi and Iizuka, Akira and Kanematsu, Akari and Ando, Takayuki and Maeda, Chie and Miyata, Haruo and Yamashita, Kazue and Ikeya, Tomoatsu and Kikuchi, Yasufumi and Maruyama, Kouji and Nagashima, Takeshi and Urakami, Kenichi and Yamaguchi, Ken and Akiyama, Yasuto},
  title = {In Vivo Antitumor Activity of the PD-1/PD-L1 Inhibitor SCL-1 in Various Mouse Tumor Models},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13805}
}
Kostenlos starten →